Essex Woodlands Management, Inc.
In its 13F for Q2 2024 (holdings as of June 30, 2024, filed August 14, 2024), Essex Woodlands Management, Inc. reported 7 stock positions worth $306.7 million. Its top holding was Mimedx (MDXG) at 63.7% of the portfolio, followed by Bioventus Class A (BVS, 24.4%) and Tela Bio (TELA, 6.3%). Its holdings were unchanged from Q1 2024.
- Most Recent 13F
- Q2 2026
- Location
- THE WOODLANDS, TX
- CIK
- 0001542339
- Portfolio Value
- $306.7M (Q2 2024)
- SEC Filing
- 0001398344-24-014608 ↗ filed Aug 14, 2024
Holdings Value
Holdings 7 stocks · $306.7M
| MDXG Mimedx Group Inc. | 63.71% | 28,195,249 | $195.4M | No change |
| BVS Bioventus Inc. Class A | 24.41% | 13,021,324 | $74.9M | No change |
| TELA Tela Bio Inc. | 6.30% | 4,110,709 | $19.3M | No change |
| EYPT Eyepoint Inc. | 4.40% | 1,551,521 | $13.5M | No change |
| MNOV Medicinova Inc. | 0.52% | 1,105,941 | $1.6M | No change |
| RVNC Revance Therapeutics Inc. | 0.38% | 457,085 | $1.2M | No change |
| VENUS CONCEPT INC | 0.28% | 1,089,190 | $853K | No change |
Portfolio Sells Q1 2024 → Q2 2024
| None this quarter. | |||
Portfolio Buys Q1 2024 → Q2 2024
| None this quarter. | |||
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 5 | $254.2M | BVS, MDXG, EYPT, TELA, MNOV |
| Q1 2026 | 5 | $250.5M | BVS, MDXG, EYPT, TELA, MNOV |
| Q4 2025 | 6 | $318.3M | MDXG, BVS, EYPT, TELA, MNOV |
| Q3 2025 | 6 | $307.1M | MDXG, BVS, EYPT, TELA, MNOV |
| Q2 2025 | 6 | $279.1M | MDXG, BVS, EYPT, TELA, MNOV |
| Q1 2025 | 6 | $346.7M | MDXG, BVS, EYPT, TELA, MNOV |
| Q4 2024 | 7 | $433.2M | MDXG, BVS, TELA, EYPT, MNOV |
| Q3 2024 | 7 | $350.4M | MDXG, BVS, EYPT, TELA, RVNC |
| Q2 2024 | 7 | $306.7M | MDXG, BVS, TELA, EYPT, MNOV |
| Q1 2024 | 7 | $344.8M | MDXG, BVS, EYPT, TELA, RVNC |